Cambridge Trust’s Dentsply Sirona XRAY Stock Holding History

Cambridge Trust’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-29	Closed	-$1K	–	909
2022 Q3	$1K	Sell	29 -124	-81%	-$4.24K	﹤0.01%	837
2022 Q2	$5K	Buy	+153	New	+$6.19K	﹤0.01%	751

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cambridge Trust's XRAY Position: Q4 2022 in Review

Cambridge Trust sold out of Dentsply Sirona (XRAY) in Q4 2022, closing a stake of 29 shares — an estimated $1K sold.

Cambridge Trust first reported a position in XRAY in Q2 2022 and held it in 2 quarters. The position peaked at $5K in Q2 2022. 436 funds tracked by Wall St. Rank hold XRAY as of Q4 2022.

Cambridge Trust reported no remaining Dentsply Sirona position as of Q4 2022 after selling out during the quarter.
Cambridge Trust sold 29 Dentsply Sirona shares in Q4 2022, an estimated $1K.
Cambridge Trust first reported a position in Dentsply Sirona in Q2 2022 and held it in 2 quarters.
Cambridge Trust's Dentsply Sirona position peaked at $5K in Q2 2022.
436 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2022.

Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.